Table S4. Comparison of the concordance rate of cutoff values in different stages in diagnosis of SCLC.
Variable | ProGRP ≥66 ng/L | ProGRP ≥300 ng/L | |||||
---|---|---|---|---|---|---|---|
Consistent | Inconsistent | P | Consistent | Inconsistent | P | ||
ProGRP ≥56 ng/L | <0.001 | <0.001 | |||||
Consistent | 2,702 | 4 | 2,663 | 40 | |||
Inconsistent | 141 | 88 | 210 | 22 | |||
ProGRP ≥71 ng/L | <0.001 | <0.001 | |||||
Consistent | 1,650 | 10 | 1,592 | 63 | |||
Inconsistent | 1 | 89 | 37 | 58 | |||
ProGRP ≥99 ng/L | <0.001 | <0.001 | |||||
Consistent | 2,079 | 64 | 2,011 | 32 | |||
Inconsistent | 7 | 69 | 16 | 60 |
Consistent, the pathological type determined by tumor marker was same as the results of living tissue; Inconsistent, the pathological type determined by tumor marker was different from the results of living tissue. SCLC, small cell lung cancer; ProGRP, roles of gastrin-releasing peptide.